Abstract:Abstract The fusion gene of ABL1 is closely related to tumor proliferation, invasion, and migration. It has been reported recently that ABL1 itself is required for T-cell acute lymphoblastic leukemia (T-ALL) cell migration induced by CXCL12. Further experiments revealed that ABL1 inhibitor Nilotinib inhibited leukemia cell migration induced by CXCL12, indicating the possible application of Nilotinib in T-ALL leukemia treatment. However, the interacting proteins of ABL1 and the specific mechanisms of their involvement in this process need further investigation. In the present study, ABL1 interacting proteins were characterized and their roles in the process of leukemia cell migration induced by CXCL12 were investigated. Co-immunoprecipitation in combination with mass spectrometry analysis identified 333 proteins that interact with ABL1, including Cofilin1. Gene ontology analysis revealed that many of them were enriched in the intracellular organelle or cytoplasm, including nucleic acid binding components, transfectors, or co-transfectors. Kyoto Encyclopedia of Genes and Genomes analysis showed that the top three enriched pathways were translation, glycan biosynthesis, and metabolism, together with human diseases. ABL1 and Cofilin1 were in the same complex. Cofilin1 binds the SH3 domain of ABL1 directly; however, ABL1 is not required for the phosphorylation of Cofilin1. Molecular docking analysis shows that ABL1 interacts with Cofilin1 mainly through hydrogen bonds and ionic interaction between amino acid residues. The mobility of leukemic cells was significantly decreased by Cofilin1 siRNA. These results demonstrate that Cofilin1 is a novel ABL1 binding partner. Furthermore, Cofilin1 participates in the migration of leukemia cells induced by CXCL12. These data indicate that ABL1 and Cofilin1 are possible targets for T-ALL treatment.

RIN1 is an ABL tyrosine kinase activator and a regulator of epithelial-cell adhesion and migration.

The Ras Effector Rin1 Directly Competes with Raf and is Regulated by 14-3-3 Proteins

RAS Interaction with Effector Target RIN 1

Abi1 Gene Silencing by Short Hairpin RNA Impairs Bcr-Abl-induced Cell Adhesion and Migration in Vitro and Leukemogenesis in Vivo

Abl Interactor 1 Regulates Src-Id1-matrix Metalloproteinase 9 Axis and is Required for Invadopodia Formation, Extracellular Matrix Degradation and Tumor Growth of Human Breast Cancer Cells

ABL1 and Cofilin1 promote T-cell acute lymphoblastic leukemia cell migration

RIN1 Promotes Renal Cell Carcinoma Malignancy by Activating EGFR Signaling Through Rab25.

Bcr-Abl Induces Abnormal Cytoskeleton Remodeling, Β1 Integrin Clustering and Increased Cell Adhesion to Fibronectin Through the Abl Interactor 1 Pathway

CRIM1, a Newfound Cancer-Related Player, Regulates the Adhesion and Migration of Lung Cancer Cells

Rictor Promotes Cell Migration And Actin Polymerization Through Regulating Ablim1 Phosphorylation In Hepatocellular Carcinoma

Development of Abl Interactor Protein 1 on Basic and Clinical Research of Oncology

AHI-1 Interacts with BCR-ABL and Modulates BCR-ABL Transforming Activity and Imatinib Response of CML Stem/progenitor Cells

Rin1 Interacts with Signal-transducing Adaptor Molecule (STAM) and Mediates Epidermal Growth Factor Receptor Trafficking and Degradation

c-Abl Kinase Targets Tight Junction Protein ZO-2 in Regulation of Cell Migration and Morphology

Rac1 Activation Controls Nuclear Localization of β-catenin during Canonical Wnt Signaling

ABLIM1, a novel ubiquitin E3 ligase, promotes growth and metastasis of colorectal cancer through targeting IĸBα ubiquitination and activating NF-ĸB signaling

The role of RAS effectors in BCR/ABL induced chronic myelogenous leukemia

RIN3 Is a Negative Regulator of Mast Cell Responses to SCF

The Abl/Abi signaling links WAVE regulatory complex to Cbl E3 ubiquitin ligase and is essential for breast cancer cell metastasis

Ras and Rab Interactor 3: from Cellular Mechanisms to Human Diseases

ABL SH3 mutant inhibits BCR-ABL activity and increases imatinib sensitivity by targeting RIN1 protein in CML cell